标题
IL-12 Family Cytokines in Cancer and Immunotherapy
作者
关键词
-
出版物
Cancers
Volume 13, Issue 2, Pages 167
出版商
MDPI AG
发表日期
2021-01-06
DOI
10.3390/cancers13020167
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Dual-target IL-12-containing nanoparticles enhance T cell functions for cancer immunotherapy
- (2020) Jieyu Li et al. CELLULAR IMMUNOLOGY
- IL-23 and PSMA-targeted duo-CAR T cells in Prostate Cancer Eradication in a preclinical model
- (2020) Dawei Wang et al. Journal of Translational Medicine
- The significance of exosomes in the development and treatment of hepatocellular carcinoma
- (2020) Xin Li et al. Molecular Cancer
- Interleukin-23 engineering improves CAR T cell function in solid tumors
- (2020) Xingcong Ma et al. NATURE BIOTECHNOLOGY
- B cell–Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer
- (2020) Bhalchandra Mirlekar et al. Cancer Immunology Research
- IL-12 regulates the expansion, phenotype, and function of murine NK cells activated by IL-15 and IL-18
- (2020) Naoto Oka et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The interleukin 22 pathway interacts with mutant KRAS to promote poor prognosis in colon cancer
- (2020) Sarah McCuaig et al. CLINICAL CANCER RESEARCH
- Intra-Tumoral Delivery of IL-27 Using Adeno-Associated Virus Stimulates Anti-tumor Immunity and Enhances the Efficacy of Immunotherapy
- (2020) Aiyan Hu et al. Frontiers in Cell and Developmental Biology
- CXCL5 promotes gastric cancer metastasis by inducing epithelial-mesenchymal transition and activating neutrophils
- (2020) Zheying Mao et al. Oncogenesis
- IL-27 Regulated CD4+IL-10+ T Cells in Experimental Sjögren Syndrome
- (2020) Jingjing Qi et al. Frontiers in Immunology
- Tumor-Educated Neutrophils Activate Mesenchymal Stem Cells to Promote Gastric Cancer Growth and Metastasis
- (2020) Jiahui Zhang et al. Frontiers in Cell and Developmental Biology
- Intratumoral interleukin-12 mRNA therapy promotes TH1 transformation of the tumor microenvironment
- (2020) Susannah L Hewitt et al. CLINICAL CANCER RESEARCH
- RORC overexpression as a sign of Th17 lymphocytes accumulation in multiple myeloma bone marrow
- (2020) Ahlem Ben Hmid et al. CYTOKINE
- Localized Interleukin-12 for Cancer Immunotherapy
- (2020) Khue G. Nguyen et al. Frontiers in Immunology
- Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities
- (2020) Gloria Pastor-Fernández et al. Cells
- NCR− group 3 innate lymphoid cells orchestrate IL-23/IL-17 axis to promote hepatocellular carcinoma development
- (2019) Yonghao Liu et al. EBioMedicine
- IL-27 confers a protumorigenic activity of regulatory T cells via CD39
- (2019) Young-Jun Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Umbilical cord blood‑derived Helios‑positive regulatory T�cells promote angiogenesis in acute lymphoblastic leukemia in mice via CCL22 and the VEGFA‑VEGFR2 pathway
- (2019) Xue Li et al. Molecular Medicine Reports
- Correction to: IL-39 acts as a friend to pancreatic cancer
- (2019) Alicia A. Manning et al. MEDICAL ONCOLOGY
- Human neutrophils activated via TLR8 promote Th17 polarization through IL-23
- (2019) Nicola Tamassia et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
- (2019) Chengcheng Jin et al. CELL
- Increased expression of the immunosuppressive interleukin-35 in patients with non-small cell lung cancer
- (2019) Lisanne Heim et al. BRITISH JOURNAL OF CANCER
- IL23-Producing Human Lung Cancer Cells Promote Tumor Growth via Conversion of Innate Lymphoid Cell 1 (ILC1) into ILC3
- (2019) Jaemoon Koh et al. CLINICAL CANCER RESEARCH
- IL23 induces IL23R recycling and amplifies innate receptor-induced signalling and cytokines in human macrophages, and the IBD-protective IL23R R381Q variant modulates these outcomes
- (2019) Rui Sun et al. GUT
- The Immunobiology of the Interleukin-12 Family: Room for Discovery
- (2019) Elia D. Tait Wojno et al. IMMUNITY
- Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3–Targeted Chimeric Antigen Receptor–Engineered T Cells in Hepatocellular Carcinoma
- (2019) Ying Liu et al. JOURNAL OF IMMUNOLOGY
- Poly(I:C)-Mediated Death of Human Prostate Cancer Cell Lines Is Induced by Interleukin-27 Treatment
- (2019) Olena Kourko et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Interleukin‑35 is associated with the tumorigenesis and progression of prostate cancer
- (2019) Jialin Zhu et al. Oncology Letters
- Diagnostic and prognostic value of serum IL-23 in colorectal cancer
- (2019) Dina F. Elessawi et al. Arab Journal of Gastroenterology
- Interleukin-35 Dampens CD8+ T Cells Activity in Patients With Non-viral Hepatitis-Related Hepatocellular Carcinoma
- (2019) Lanlan Yang et al. Frontiers in Immunology
- IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells
- (2019) Yeon Ho Choi et al. Journal for ImmunoTherapy of Cancer
- Evidence for IL-35 Expression in Diffuse Large B-Cell Lymphoma and Impact on the Patient's Prognosis
- (2019) Frédérique Larousserie et al. Frontiers in Oncology
- Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
- (2019) E. Antonio Chiocca et al. Science Translational Medicine
- IL-35 inhibits CD8+ T cells activity by suppressing expression of costimulatory molecule CD28 and Th1 cytokine production
- (2019) Hua Jiang et al. Translational Cancer Research
- Peritumoural CCL1 and CCL22 expressing cells in hepatocellular carcinomas shape the tumour immune infiltrate
- (2019) Gabriela M. Wiedemann et al. PATHOLOGY
- Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment
- (2019) Bradley N. Mills et al. Cell Reports
- JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation
- (2019) Dagmar Gotthardt et al. Frontiers in Immunology
- Mechanisms regulating PD-L1 expression on tumor and immune cells
- (2019) Shuming Chen et al. Journal for ImmunoTherapy of Cancer
- P-MAPA and Interleukin-12 Reduce Cell Migration/Invasion and Attenuate the Toll-Like Receptor-Mediated Inflammatory Response in Ovarian Cancer SKOV-3 Cells: A Preliminary Study
- (2019) Luiz Antonio Lupi et al. MOLECULES
- Non-small Cell Lung Cancer Cells Modulate the Development of Human CD1c+ Conventional Dendritic Cell Subsets Mediated by CD103 and CD205
- (2019) Yong Lu et al. Frontiers in Immunology
- Interleukin-35 Suppresses the Antitumor Activity of T Cells in Patients with Non-Small Cell Lung Cancer
- (2018) Hong-Min Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors
- (2018) Jiemiao Hu et al. CLINICAL CANCER RESEARCH
- Revisiting Interleukin-12 as a Cancer Immunotherapy Agent
- (2018) Pedro Berraondo et al. CLINICAL CANCER RESEARCH
- IL-35-producing B cells in gastric cancer patients
- (2018) Ke Wang et al. MEDICINE
- Role of IL-23 signaling in the progression of premalignant oral lesions to cancer
- (2018) Blaine Caughron et al. PLoS One
- Expression of IL-23R and IL-17 and the pathology and prognosis of urinary bladder carcinoma
- (2018) Jian Liu et al. Oncology Letters
- IL23 and TGF-ß diminish macrophage associated metastasis in pancreatic carcinoma
- (2018) S. Mazher Hussain et al. Scientific Reports
- Targeting interleukin-22 for cancer therapy
- (2018) Anamarija Markota et al. Human Vaccines & Immunotherapeutics
- IL-35 hinders endogenous anti-tumor T cell immunity and responsiveness to immunotherapy in pancreatic cancer
- (2018) Bhalchandra Mirlekar et al. Cancer Immunology Research
- Rapamycin Synergizes with Cisplatin in Antiendometrial Cancer Activation by Improving IL-27–Stimulated Cytotoxicity of NK Cells
- (2018) Wen-Jie Zhou et al. NEOPLASIA
- CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity
- (2018) Gray Kueberuwa et al. Molecular Therapy-Oncolytics
- Administration of Interleukin-35-Conditioned Autologous Tolerogenic Dendritic Cells Prolong Allograft Survival After Heart Transplantation
- (2018) Xianglan Liu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Serum concentration of interleukin-35 and its association with tumor stages and FOXP3 gene polymorphism in patients with prostate cancer
- (2018) Nazanin Chatrabnous et al. CYTOKINE
- Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis
- (2018) Jason E. Hawkes et al. JOURNAL OF IMMUNOLOGY
- The PD-L1- and IL6-mediated dampening of the IL27/STAT1 anticancer responses are prevented by α-PD-L1 or α-IL6 antibodies
- (2018) Catherine Rolvering et al. JOURNAL OF LEUKOCYTE BIOLOGY
- IL-23 secreted by myeloid cells drives castration-resistant prostate cancer
- (2018) Arianna Calcinotto et al. NATURE
- Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization
- (2018) Chih-Chan Lee et al. Nature Communications
- Interleukin-12p35 Knock Out Aggravates Doxorubicin-Induced Cardiac Injury and Dysfunction by Aggravating the Inflammatory Response, Oxidative Stress, Apoptosis and Autophagy in Mice
- (2018) Jing Ye et al. EBioMedicine
- Ex vivo conditioning with IL-12 protects tumor-infiltrating CD8+ T cells from negative regulation by local IFN-γ
- (2018) Lin Lin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Breast cancer cell–derived IL-35 promotes tumor progression via induction of IL-35-producing induced regulatory T cells
- (2018) Shengnan Hao et al. CARCINOGENESIS
- IL-23 in inflammatory bowel diseases and colon cancer
- (2018) Markus F. Neurath CYTOKINE & GROWTH FACTOR REVIEWS
- Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion
- (2018) Qiang Fu et al. EUROPEAN UROLOGY
- Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
- (2018) Christopher S. Garris et al. IMMUNITY
- IL-27 mediates HLA class I up-regulation, which can be inhibited by the IL-6 pathway, in HLA-deficient Small Cell Lung Cancer cells
- (2017) Grazia Carbotti et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Dual Roles of IL-27 in Cancer Biology and Immunotherapy
- (2017) Marina Fabbi et al. MEDIATORS OF INFLAMMATION
- Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer
- (2017) Juming Yan et al. Cold Spring Harbor Perspectives in Biology
- IL-27 triggers IL-10 production in Th17 cells via a c-Maf/RORγt/Blimp-1 signal to promote the progression of endometriosis
- (2017) Kai-Kai Chang et al. Cell Death & Disease
- IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease
- (2017) Ivy M. Dambuza et al. Nature Communications
- Interleukin-35 expression is associated with colon cancer progression
- (2017) Jian Zhang et al. Oncotarget
- Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity
- (2017) QiangYue Jiang et al. Oncotarget
- IL-35 induces N2 phenotype of neutrophils to promote tumor growth
- (2017) Jiu-Ming Zou et al. Oncotarget
- Enhanced antitumor effects by combining an IL-12/anti-DNA fusion protein with avelumab, an anti-PD-L1 antibody
- (2017) Jonathan K. Fallon et al. Oncotarget
- CCL3 Enhances Antitumor Immune Priming in the Lymph Node via IFNγ with Dependency on Natural Killer Cells
- (2017) Frederick Allen et al. Frontiers in Immunology
- Regulation of NK Cell Activation and Effector Functions by the IL-12 Family of Cytokines: The Case of IL-27
- (2017) Norberto Walter Zwirner et al. Frontiers in Immunology
- Interleukin-35-Producing CD8α+ Dendritic Cells Acquire a Tolerogenic State and Regulate T Cell Function
- (2017) Sergio Haller et al. Frontiers in Immunology
- CCL3 augments tumor rejection and enhances CD8+ T cell infiltration through NK and CD103+ dendritic cell recruitment via IFNγ
- (2017) Frederick Allen et al. OncoImmunology
- Intra-tumoral production of IL18, but not IL12, by TCR-engineered T cells is non-toxic and counteracts immune evasion of solid tumors
- (2017) A. Kunert et al. OncoImmunology
- Tumor-targeted IL-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo
- (2017) Franziska Eckert et al. OncoImmunology
- IL-6/IL-12 Cytokine Receptor Shuffling of Extra- and Intracellular Domains Reveals Canonical STAT Activation via Synthetic IL-35 and IL-39 Signaling
- (2017) D. M. Floss et al. Scientific Reports
- Association between IL-27 2905T/G genotypes and the risk and survival of cervical cancer: a case-control study
- (2016) Guo-Qing Wang et al. BIOMARKERS
- Toxicities of chimeric antigen receptor T cells: recognition and management
- (2016) Jennifer N. Brudno et al. BLOOD
- IL-17A-producing CD30+Vδ1 T cells drive inflammation-induced cancer progression
- (2016) Yoshitaka Kimura et al. CANCER SCIENCE
- An IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphoma
- (2016) Hasita Horlad et al. CANCER SCIENCE
- Interleukin (IL)-39 [IL-23p19/Epstein-Barr virus-induced 3 (Ebi3)] induces differentiation/expansion of neutrophils in lupus-prone mice
- (2016) X. Wang et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Molecular Pathways: Interleukin-35 in Autoimmunity and Cancer
- (2016) Y. Pylayeva-Gupta CLINICAL CANCER RESEARCH
- A novel IL-23p19/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice
- (2016) Xiaoqian Wang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interleukin-35 Limits Anti-Tumor Immunity
- (2016) Meghan E. Turnis et al. IMMUNITY
- Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
- (2016) Ana C. Anderson et al. IMMUNITY
- Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model
- (2016) Adel Galal El-Shemi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- mTOR Mediates IL-23 Induction of Neutrophil IL-17 and IL-22 Production
- (2016) Feidi Chen et al. JOURNAL OF IMMUNOLOGY
- IL-35 Decelerates the Inflammatory Process by Regulating Inflammatory Cytokine Secretion and M1/M2 Macrophage Ratio in Psoriasis
- (2016) Junfeng Zhang et al. JOURNAL OF IMMUNOLOGY
- IL-27 suppresses SKOV3 cells proliferation by enhancing STAT3 and inhibiting the Akt signal pathway
- (2016) Zhu Zhang et al. MOLECULAR IMMUNOLOGY
- IL-35 expression in hepatocellular carcinoma cells is associated with tumor progression
- (2016) Jun Long et al. Oncotarget
- Elevated level of Interleukin-35 in colorectal cancer induces conversion of T cells into iTr35 by activating STAT1/STAT3
- (2016) Yanhui Ma et al. Oncotarget
- Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation
- (2016) Konrad Aden et al. Cell Reports
- Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family
- (2016) Hideaki Hasegawa et al. Frontiers in Immunology
- CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment
- (2016) Evelina Martinenaite et al. OncoImmunology
- The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27
- (2016) Sènan M. d’Almeida et al. OncoImmunology
- Toxicity and management in CAR T-cell therapy
- (2016) Challice L Bonifant et al. Molecular Therapy-Oncolytics
- Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1
- (2015) Hui-Hua Chang et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Interleukin-12: Functional activities and implications for disease
- (2015) Sebastian Zundler et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members
- (2015) Karen O. Dixon et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Elevated IL-35 in bone marrow of the patients with acute myeloid leukemia
- (2015) Jia Wang et al. HUMAN IMMUNOLOGY
- Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
- (2015) Jacob S. Lee et al. IMMUNITY
- Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine Specificity
- (2015) Kiyoshi Hirahara et al. IMMUNITY
- Innate lymphoid cells involve in tumorigenesis
- (2015) Zhiqiang Tian et al. INTERNATIONAL JOURNAL OF CANCER
- Regulatory T cells-derived IL-35 promotes the growth of adult acute myeloid leukemia blasts
- (2015) Qianshan Tao et al. INTERNATIONAL JOURNAL OF CANCER
- The Expression Levels of Transcription Factors T-bet, GATA-3, RORγt and FOXP3 in Peripheral Blood Lymphocyte (PBL) of Patients with Liver Cancer and their Significance
- (2015) Ze-Wei Lin et al. International Journal of Medical Sciences
- Interleukin-27 in T Cell Immunity
- (2015) Yukiko Iwasaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Administration of DNA Encoding the Interleukin-27 Gene Augments Antitumour Responses through Non-adaptive Immunity
- (2015) Q. Li et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer
- (2015) Xiaoqin Wu et al. TUMOR BIOLOGY
- Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer
- (2015) Irma Airoldi et al. Oncotarget
- IL-27 induces the expression of IDO and PD-L1 in human cancer cells
- (2015) Grazia Carbotti et al. Oncotarget
- Th17 Cell Plasticity and Functions in Cancer Immunity
- (2015) Leslie Guéry et al. Biomed Research International
- IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumorsin vivo
- (2015) Mythili Koneru et al. OncoImmunology
- Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer
- (2015) Bo Pan et al. Scientific Reports
- The prognostic value of preoperative serum levels of IL-12p40 and IL-23 for survival of patients with colorectal cancer
- (2014) Noyko Stanilov et al. APMIS
- IL-17A Produced by T Cells Promotes Tumor Growth in Hepatocellular Carcinoma
- (2014) S. Ma et al. CANCER RESEARCH
- New insights into IL-12-mediated tumor suppression
- (2014) S Tugues et al. CELL DEATH AND DIFFERENTIATION
- IL-35 promotes pancreas cancer growth through enhancement of proliferation and inhibition of apoptosis: Evidence for a role as an autocrine growth factor
- (2014) Michael B. Nicholl et al. CYTOKINE
- Interleukin-17 Receptor A Signaling in Transformed Enterocytes Promotes Early Colorectal Tumorigenesis
- (2014) Kepeng Wang et al. IMMUNITY
- Interleukin-35 induces regulatory B cells that suppress autoimmune disease
- (2014) Ren-Xi Wang et al. NATURE MEDICINE
- Selected Cytokines in Patients with Pancreatic Cancer: A Preliminary Report
- (2014) Wojciech Błogowski et al. PLoS One
- Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironment
- (2014) Qiuyang Zhang et al. PROSTATE
- Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
- (2014) Nan Wang et al. Frontiers in Immunology
- Th17 Cells in Cancer: The Ultimate Identity Crisis
- (2014) Stefanie R. Bailey et al. Frontiers in Immunology
- Circulating IL-35 in pancreatic ductal adenocarcinoma patients
- (2013) Peng Jin et al. HUMAN IMMUNOLOGY
- STAT4 and T-bet Are Required for the Plasticity of IFN- Expression across Th2 Ontogeny and Influence Changes in Ifng Promoter DNA Methylation
- (2013) C. L. Williams et al. JOURNAL OF IMMUNOLOGY
- Tumor-Derived IL-35 Promotes Tumor Growth by Enhancing Myeloid Cell Accumulation and Angiogenesis
- (2013) Z. Wang et al. JOURNAL OF IMMUNOLOGY
- Increased Th17 Cells in the Tumor Microenvironment Is Mediated by IL-23 via Tumor-Secreted Prostaglandin E2
- (2013) X. Qian et al. JOURNAL OF IMMUNOLOGY
- IL-27 in tumor immunity and immunotherapy
- (2013) Gopal Murugaiyan et al. TRENDS IN MOLECULAR MEDICINE
- Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor
- (2012) Jun Li et al. CARCINOGENESIS
- Local Delivery of lnterleukin-12 Using T Cells Targeting VEGF Receptor-2 Eradicates Multiple Vascularized Tumors in Mice
- (2012) D. Chinnasamy et al. CLINICAL CANCER RESEARCH
- Increased Th17 and Regulatory T Cell Responses in EBV-Induced Gene 3-Deficient Mice Lead to Marginally Enhanced Development of Autoimmune Encephalomyelitis
- (2012) J.-Q. Liu et al. JOURNAL OF IMMUNOLOGY
- IL-23 is pro-proliferative, epigenetically regulated and modulated by chemotherapy in non-small cell lung cancer
- (2012) Anne-Marie Baird et al. LUNG CANCER
- Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
- (2012) Sergei I. Grivennikov et al. NATURE
- The composition and signaling of the IL-35 receptor are unconventional
- (2012) Lauren W Collison et al. NATURE IMMUNOLOGY
- IL-12 family cytokines: immunological playmakers
- (2012) Dario A A Vignali et al. NATURE IMMUNOLOGY
- Differential Effects of IL-12 on Tregs and Non-Treg T Cells: Roles of IFN-γ, IL-2 and IL-2R
- (2012) Jingxian Zhao et al. PLoS One
- Interleukin 23 Promotes Hepatocellular Carcinoma Metastasis via NF-Kappa B Induced Matrix Metalloproteinase 9 Expression
- (2012) Jian Li et al. PLoS One
- Interleukin-35 Mediates Mucosal Immune Responses That Protect Against T-Cell–Dependent Colitis
- (2011) Stefan Wirtz et al. GASTROENTEROLOGY
- IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
- (2011) Sid P. Kerkar et al. JOURNAL OF CLINICAL INVESTIGATION
- Involvement of CCR6/CCL20/IL-17 Axis in NSCLC Disease Progression
- (2011) Sophie Kirshberg et al. PLoS One
- Induction of regulatory Tr1 cells and inhibition of TH17 cells by IL-27
- (2011) Caroline Pot et al. SEMINARS IN IMMUNOLOGY
- Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells
- (2010) C. Cocco et al. BLOOD
- Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
- (2010) S. P. Kerkar et al. CANCER RESEARCH
- IL-27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells
- (2010) Raphael Schneider et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IL-23 promotes growth and proliferation in human squamous cell carcinoma of the oral cavity
- (2010) Fukuda INTERNATIONAL JOURNAL OF ONCOLOGY
- Interleukin-27 Induces a STAT1/3- and NF-κB-dependent Proinflammatory Cytokine Profile in Human Monocytes
- (2010) Christina Guzzo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Pivotal Role for Interleukin-27 in CD8+T Cell Functions and Generation of Cytotoxic T Lymphocytes
- (2010) Noriko Morishima et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Molecular Pathways in the Induction of Interleukin-27-Driven Regulatory Type 1 Cells
- (2010) Caroline Pot et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- T-bet represses TH17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt
- (2010) Vanja Lazarevic et al. NATURE IMMUNOLOGY
- IL-35-mediated induction of a potent regulatory T cell population
- (2010) Lauren W Collison et al. NATURE IMMUNOLOGY
- Interleukin 12 Stimulates IFN- -Mediated Inhibition of Tumor-Induced Regulatory T-Cell Proliferation and Enhances Tumor Clearance
- (2009) X. Cao et al. CANCER RESEARCH
- IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
- (2009) Lin Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-27 Is a Key Regulator of IL-10 and IL-17 Production by Human CD4+ T Cells
- (2009) G. Murugaiyan et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: IL-27 Induces the Transcription Factor c-Maf, Cytokine IL-21, and the Costimulatory Receptor ICOS that Coordinately Act Together to Promote Differentiation of IL-10-Producing Tr1 Cells
- (2009) C. Pot et al. JOURNAL OF IMMUNOLOGY
- A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies
- (2009) T. S. Bekaii-Saab et al. MOLECULAR CANCER THERAPEUTICS
- The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes
- (2009) R. G. Jenner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of the class II and class I MHC pathways in human THP-1 monocytic cells by interleukin-27
- (2008) Xiao Ming Feng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Signal Transducer and Activator of Transcription 4 Is Required for the Transcription Factor T-bet to Promote T Helper 1 Cell-Fate Determination
- (2008) Vivian T. Thieu et al. IMMUNITY
- Signal transducer and activator of transcription 4 limits the development of adaptive regulatory T cells
- (2008) John T. O’Malley et al. IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started